FIELD: chemistry of peptides, medicine, pharmacy.
SUBSTANCE: invention relates to compound of the formula (I): wherein R1 represents benzofuranyl substituted with halogen atom or styryl substituted with halogen atom; R2 represents substituted hydroxyl substituted with mercapto-group or substituted sulfonyl, or its pharmaceutically acceptable salts. Compound of the formula (I) and its pharmaceutically acceptable salts possess the strong inhibitory effect on production of nitrogen oxide (NO) and can be useful in prophylaxis and/or treatment of NO-mediated diseases in humans and animals.
EFFECT: valuable medicinal and biochemical properties of compounds.
Title | Year | Author | Number |
---|---|---|---|
CYCLOALKANE DERIVATIVE | 2013 |
|
RU2635354C2 |
1,2,4-TRIAZOLONE DERIVATIVE | 2011 |
|
RU2566754C2 |
INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
DIAMINE DERIVATIVES | 2003 |
|
RU2333203C2 |
PYRIDOPYRIMIDINONE DERIVATIVES AND USE THEREOF AS AROMATIC HYDROCARBON RECEPTOR MODULATORS | 2021 |
|
RU2818954C1 |
SERINE DERIVATIVES AS GHRELIN RECEPTOR AGONISTS | 2015 |
|
RU2695649C2 |
DERIVATIVES OF DIAMINES | 2002 |
|
RU2319699C2 |
IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AS KINASE INHIBITORS | 2013 |
|
RU2635917C2 |
QUINOLINE AND QUINAZOLINE DERIVATIVES | 2000 |
|
RU2256654C2 |
TRIAZOLE[4,5-d]PYRIMIDINE DERIVATIVES AND USES THEREOF AS PUTINOCEPTOR ANTAGONISTS | 2002 |
|
RU2317084C2 |
Authors
Dates
2006-08-20—Published
2001-12-18—Filed